Neutrogena is facing renewed online criticism over its past relationship with actress Hayden Panettiere. The controversy has grown quickly after comments from Panettiere resurfaced following her death
Fans are questioning how the skincare brand handled her disclosure about postpartum depression and why their long-running partnership ended.
The issue has also put pressure on the leadership of Neutrogena’s parent company, Kenvue. This is important because Neutrogena does not have a standalone public-company CEO.
The brand operates under Kenvue, whose current CEO is Kirk Perry. Kenvue’s portfolio includes Neutrogena along with other major consumer health brands. The backlash is not simply about an old celebrity endorsement deal.
It has become a wider discussion about mental health, postpartum depression, corporate responsibility and how companies treat public figures who speak openly about difficult personal experiences. Neutrogena has now responded.
However, critics argue that the response came too late and did not answer some of the biggest questions surrounding Panettiere’s account.
Also Read: Angela Nikolau Age, Bio, Career, Relationship and Net Worth 2026
Table of Contents
Who Is the Neutrogena CEO?
There is an important distinction when discussing the “Neutrogena CEO.”1
Neutrogena is a consumer skincare brand rather than a separate publicly traded company. It is part of Kenvue’s portfolio.
As of 2026, Kirk Perry is the CEO of Kenvue, the company behind Neutrogena. Kenvue officially lists Perry as its Chief Executive Officer and director.
He previously served as president and CEO of Circana. Before that he held senior leadership positions at Google and spent more than two decades at Procter & Gamble.
Perry became Kenvue’s permanent CEO in November 2025 after initially taking over as interim CEO in July 2025.
This means it would be inaccurate to describe Kirk Perry as the person who personally made the decision involving Panettiere in 2015. Perry was not Kenvue’s CEO at that time and the current corporate structure did not exist in its present form.
Kenvue was created later when Johnson & Johnson separated its consumer health business. Neutrogena became part of Kenvue’s portfolio.
So the current controversy involves the Neutrogena brand and its corporate leadership today but the original dispute dates back more than a decade.
That distinction matters when discussing accountability.
Why Is Neutrogena Facing Backlash?
The controversy centers on Panettiere’s claim that her relationship with Neutrogena ended after she publicly discussed postpartum depression.
Panettiere worked with Neutrogena for about a decade. She became one of the recognizable faces associated with the brand and was described by Neutrogena as a valued member of its community.
In 2015, Panettiere spoke publicly about postpartum depression while discussing her character Juliette Barnes on Nashville. Her character was also dealing with postpartum depression in the television series.
Panettiere said that she personally understood the condition and believed women should be able to talk about it without shame.
Years later, she claimed that her comments created a problem with Neutrogena.
During a May 2026 appearance on the On Purpose with Jay Shetty podcast, Panettiere said she had not planned to discuss postpartum depression during the 2015 television interview.
She said the subject came up naturally and that she was simply being honest about her experience.
She also claimed that she was told Neutrogena wanted to fire her because of the discussion. Her representative reportedly pushed back at the time.
Panettiere said she eventually understood that she would not be invited back by the company after their decade-long relationship ended.
Her comments attracted renewed attention after her death in August 2026. Fans began sharing clips from the podcast and earlier interviews across social media.
That quickly turned into criticism of Neutrogena and calls from some users to boycott the brand.
Exciting news! @Neutrogena is taking skincare to the next level during #MetaverseBeautyWeek! ✨
Experience your skin’s vitals like never before with the incredible @kerrywashington as your guide as you battle 5 different skin agressors. https://t.co/WK7QtNn89U pic.twitter.com/BFAfIvyXQ6
— Neutrogena (@Neutrogena) June 15, 2023
Key Facts
| Topic | Details |
|---|---|
| Brand | Neutrogena |
| Parent company | Kenvue |
| Current Kenvue CEO | Kirk Perry |
| Former ambassador | Hayden Panettiere |
| Partnership | Approximately 2005–2015 |
| Main issue | Panettiere’s public discussion of postpartum depression |
| Later claim | She said Neutrogena wanted to end the relationship after her comments |
| Neutrogena response | The brand said she felt unsupported during a difficult time |
| New commitment | Investment in postpartum depression support |
| Current controversy | Questions about accountability, transparency and corporate responsibility |
What Happened Between Hayden Panettiere and Neutrogena?
Panettiere’s relationship with Neutrogena began around 2005 and continued for roughly ten years. She became closely associated with the brand during a period when she was also building a major acting career.2
Her public profile grew through projects such as Heroes and Nashville. She also appeared in films including Remember the Titans and Scream 4. The controversy relates to events in 2015.
Panettiere had given birth to her daughter in 2014. She later spoke publicly about postpartum depression and eventually sought treatment. During her 2015 television interview, she discussed the condition in an effort to raise awareness.
She said many women experience postpartum depression and argued that people should be able to talk about it.
According to Panettiere’s later account, she was surprised that her comments could affect her professional relationship with Neutrogena.
In the 2026 podcast interview, she described the brand as a major part of her life and said she was shocked by what happened afterward. She claimed her representative told the company that ending the relationship because of her disclosure could be illegal.
Panettiere said she believed that intervention prevented an immediate termination but that she ultimately expected the partnership would not continue.
NBC News reported that Panettiere said she had worked with the company for 10 years and felt hurt that she did not receive a proper goodbye from the people she had worked with.
What Did Neutrogena Say?
Neutrogena eventually addressed the controversy publicly in August 2026. The company said it was deeply saddened by Panettiere’s death and acknowledged her long relationship with the brand.
The most important part of the statement was the company’s admission that it understood it had made Panettiere feel unsupported during a difficult period. Neutrogena said this was not what the brand stands for.
The company also recognized Panettiere’s willingness to speak about her struggles and said her openness helped create important conversations around postpartum depression.
Neutrogena then announced that it would make a significant investment in a long-standing community health partner to help more women access support. The company specifically mentioned care for postpartum depression.
However, the company did not publicly provide extensive details about the original contract or explain exactly what happened in 2015.
That lack of detail is one reason the controversy has continued.
Why Did the Response Receive Criticism?
At first glance, Neutrogena’s response appeared sympathetic. The company expressed condolences.
It acknowledged Panettiere’s experience. It also announced an investment related to postpartum depression.
But public relations experts interviewed by Business Insider argued that the response had several weaknesses.
One major issue was timing. Neutrogena said it waited before commenting because it wanted to respect Panettiere’s family and loved ones.
Critics understood that reasoning but argued that the company could still have provided a clearer explanation once it decided to respond. Another problem was the language used.
The company said it understood that it had made Panettiere feel unsupported. Critics saw that as less direct than acknowledging what the company believed went wrong.
The brand also disabled comments on its Instagram post. That decision became another source of criticism because people interpreted it as an attempt to avoid public discussion.
The result was that the statement itself became part of the controversy. Instead of ending the discussion, it created additional questions.
The Bigger Question About Postpartum Depression
The Neutrogena controversy has become bigger than a celebrity endorsement dispute.3
At its center is the question of how society treats women who speak publicly about postpartum depression.
Panettiere’s 2015 comments were significant because she used her public platform to discuss something that many women experience but may hesitate to talk about.
Her story also showed how complicated the subject can become when mental health intersects with celebrity culture and professional relationships.
The CDC says postpartum depression is a serious condition that can affect women after childbirth. It is different from the short-term emotional changes commonly called the “baby blues.”
Panettiere later discussed her own struggles in interviews and in her memoir This Is Me: A Reckoning. Her openness helped bring renewed attention to postpartum depression and the stigma surrounding it.
That is why some critics believe Neutrogena’s response needs to go beyond a public statement. They want the company’s actions to match its words.
Also Read: Britt Barbie Bio: From “Period Ahh” Meme to Internet Creator
What Does This Mean for Kenvue CEO Kirk Perry?
Kirk Perry is now leading Kenvue at a time when Neutrogena is dealing with a difficult reputational issue. However, it is important not to confuse current leadership with the events of 2015.
Perry was not responsible for the original relationship with Panettiere. His challenge is different.
As Kenvue’s current CEO, he is part of the leadership environment responsible for how the company responds to major reputational issues involving its brands.
Kenvue describes itself as a major consumer health company with brands including Neutrogena, Tylenol, Listerine, Aveeno and Johnson’s. The company reported $15.1 billion in 2025 net sales.
That scale means controversies involving one brand can attract attention far beyond the original issue.
The question for current leadership is therefore less about what Perry personally did in 2015 and more about how Kenvue and Neutrogena respond now.
Neutrogena and Corporate Responsibility
Modern consumers increasingly expect companies to explain their decisions. Celebrity partnerships are no longer simply marketing arrangements.
They can become part of a company’s public identity. When a brand works with a celebrity for years, consumers often associate that person with the company.
Panettiere’s decade-long relationship with Neutrogena created that kind of connection. That is why her later account was so powerful. Consumers were not simply hearing that an old endorsement deal ended.
They were hearing that an actress believed her openness about postpartum depression contributed to the end of a professional relationship.
Whether every detail of that account can be independently verified is a separate question. Neutrogena has not publicly confirmed Panettiere’s version of the contract dispute in full.
But the brand’s own statement acknowledged that she felt unsupported. That acknowledgment has given the controversy additional weight.
What Could Neutrogena Do Next?
The brand has already promised to invest in postpartum depression support. The next step will be showing consumers what that commitment actually means.
Public relations professionals quoted by Business Insider suggested that the company should provide more information about the community health partnership and make its results transparent.
They also raised questions about how companies structure morality clauses and relationships with brand ambassadors.
Neutrogena could potentially rebuild trust by being more specific. That could include explaining the nature of its new investment, identifying the organization involved when appropriate and reporting measurable outcomes.
It could also involve reviewing how ambassador contracts address sensitive personal circumstances.
The goal would not be to rewrite what happened in 2015. Instead, it would be to show that the company learned from the controversy.
Why Is Hayden Panettiere’s Story Resonating So Strongly?
There are several reasons.
First, Panettiere’s relationship with Neutrogena lasted for years. This was not a short campaign with a celebrity who appeared in one advertisement.
Second, the subject was postpartum depression. Mental health remains a deeply personal issue. When a public figure speaks about it openly, the reaction from employers and brands can receive significant attention.
Third, Panettiere’s comments resurfaced after her death. That changed the emotional context of the story.
Fans who might not have heard the original podcast interview suddenly encountered her account through social media clips.
Finally, Neutrogena’s response arrived in the middle of a growing online conversation. The brand was no longer dealing with a private contractual disagreement. It was dealing with a public debate about its values.
Is Neutrogena Being Accused of Firing Hayden Panettiere for Discussing Postpartum Depression?
Panettiere herself made that claim.
She said during her 2026 podcast appearance that Neutrogena wanted to fire her after she spoke about postpartum depression during a 2015 television interview.
However, Neutrogena has not publicly confirmed the full details of that allegation.
The company has acknowledged that Panettiere felt unsupported but has not publicly provided a detailed account of the contract negotiations from that period.
That distinction is important. The allegation comes from Panettiere’s account while the company’s response is more limited.
What Happened to Hayden Panettiere?
Hayden Panettiere died in August 2026 at the age of 36.
Authorities said she was found unresponsive in South Carolina and the cause of death remained under investigation at the time of initial reporting.
Her death prompted renewed interest in her career, personal struggles and her previous relationship with Neutrogena.
It also led many people to revisit her comments about postpartum depression and the treatment she believed she received from the company.
View this post on Instagram
FAQ’s
Who is the CEO of Neutrogena?
Neutrogena is a brand rather than a standalone publicly traded company. It is owned by Kenvue. Kenvue’s current CEO is Kirk Perry.
Did Kirk Perry fire Hayden Panettiere?
There is no evidence that Kirk Perry personally made the decision involving Panettiere. The disputed events occurred around 2015, years before Perry became Kenvue’s CEO in 2025.
Why is Neutrogena facing backlash?
The backlash stems from Panettiere’s claim that her long-running Neutrogena partnership was effectively ended after she publicly discussed postpartum depression. Her comments resurfaced after her death and led to criticism of the brand.
What did Neutrogena say about Hayden Panettiere?
Neutrogena said Panettiere had been a valued member of its community for more than a decade and acknowledged that the company had made her feel unsupported during a difficult time.
Did Neutrogena admit it fired Hayden Panettiere because of postpartum depression?
No. Neutrogena did not publicly confirm that specific allegation. Panettiere made the claim in her 2026 podcast appearance. The company’s response acknowledged that she felt unsupported but did not provide a detailed explanation of the 2015 contract situation.
Conclusion
The Neutrogena Hayden Panettiere controversy has become one of the brand’s most difficult public relations challenges in recent years.
At the heart of the story is Panettiere’s claim that her decade-long relationship with Neutrogena was damaged after she spoke publicly about postpartum depression. Her comments were made more than a decade ago but gained new attention in 2026 after her death.
If its promised investment in postpartum depression support produces meaningful results, the company will have an opportunity to demonstrate that the lessons from the Panettiere controversy have influenced how it approaches women’s health and brand partnerships.
For now, the Hayden Panettiere story remains a wider conversation about celebrity contracts, corporate responsibility and the importance of taking mental health disclosures seriously.
